Research And Development Activities

Astellas Pharma Inc. - Filing #7332273

Concept 2023-04-01 to
2024-03-31
Research and development activities
Research and development expenses
Research and development expenses
294,200,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.